Sharechat Logo

Pacific Edge Limited (NZX: PEG) Unaudited Financial Results to 30 Sept 2020

Thursday 26th November 2020

Text too small?

Cancer diagnostics company, Pacific Edge Limited is pleased to report accelerating revenue growth in key growth markets, as it starts to benefit from the major commercial milestones achieved during the first half of the financial year.

Summary of performance for the period (% changes compared to prior comparative period (pcp)):

• Total revenue increased 50% to $4.1m

• Operating revenue from test sales increased 46% to $3.3m

• U.S. operating revenue increased 46% to $2.9m

• Three consecutive record revenue months achieved in the U.S. following LCD inclusion in July 2020, despite the ongoing negative impact from COVID-19 on test volumes

• Rest of World (ROW) operating revenue increased 40% to $0.4m, driven by strong growth in the NZ market following the lifting of Covid-19 restrictions

• Total Laboratory Throughput (TLT) reduced 16% to 6,864 tests

• ROW commercial test volumes increased 18% to 1,631 tests

• Total operating expenses reduced 8% to $11.2m

• Total Comprehensive Loss improved 25% to $7.1m

• Net cash, cash equivalents and short term deposits increased to $29.3m as at 30 September 2020, following a $22m placement to ANZ New Zealand Investments

• Commenced scale up of commercial operations in U.S. to leverage key commercial milestones of LCD inclusion and agreement with Kaiser Permanente

See the links below for more details:

HY Interim Results - Announcement

HY Interim Results - Presentation

HY Interim Results - Financial Statements

HY Interim Results - Equity and Debt - Rule 3.5

Source: Pacific Edge Limited



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Chatham Rock Phosphate Limited (NZX: CRP) Chatham Successfully Completes Private Placement
Turners Automotive Group Limited (NZX: TRA) Upgrades FY21 Earnings Guidance
Blackwell Global Holdings Limited (NZX: BGI) Restructure of Business Operations
Vista Group International Limited (NZX: VGL) Vista Group appoints James Miller as Independent Director
Rakon Limited (NZX: RAK) Update of FY2021 Earnings Guidance
The a2 Milk Company Limited (NZX: ATM) Organisational Announcement
Reserve Bank of New Zealand Committed to Action as It Responds to Data Breach
MHM Automation Limited (NZX: MHM) Settlement of New Plymouth Building Sale
Napier Port Holdings Limited (NZX: NPH) First Quarter 2021 Trade Volumes
New Zealand Oil & Gas Limited (NZX: NZO) Mahato PSC Update - Oil Production

IRG See IRG research reports